Moderna, Inc. financials

MRNA CIK 0001682852

Source: EDGAR filings · Built 2026-06-02T03:35:14Z

Key metrics by reporting period

Up to six most-recent periods side-by-side. Rows are the curated key lines — revenue, margins, cash, debt, equity, cash-flow totals, plus the derived and valuation metrics we compute on top. For every tag a filer reported in one period, use the single-filing drilldown below.

Derived Metrics

Concept FY 2025FY 2024FY 2023FY 2022FY 2021FY 2020
Free Cash Flow -2.09B -4.07B -4.12B 4.40B 13.20B 1.95B
EBITDA -2.86B -3.76B -3.62B 9.77B 13.53B -732.00M
Working Capital 4.56B 5.89B 7.31B 8.51B 6.94B 1.91B
Net Debt -1.29B -1.18B -1.66B -2.00B -5.93B -2.39B
Gross Margin 55.35% 54.76% 31.47% 71.88% 85.83% 99.00%
Operating Margin -158.13% -121.91% -61.90% 48.90% 71.98% -95.02%
Net Margin -145.16% -110.04% -68.84% 43.41% 66.06% -93.03%
Return on Equity (ROE) -32.62% -32.67% -34.03% 43.73% 86.26% -29.17%
Return on Assets (ROA) -22.87% -25.18% -25.58% 32.34% 49.46% -10.18%
Current Ratio 3.29× 3.67× 3.42× 2.73× 1.76× 1.44×
Debt-to-Equity 0.15× 0.07× 0.09× 0.06× 0.06× 0.09×
Effective Tax Rate -1.95% 1.28% -19.58% 12.67% 8.15% -0.40%
Cash Conversion Ratio 0.66× 0.84× 0.66× 0.60× 1.12× -2.71×
Accruals Ratio -0.08× -0.04× -0.09× 0.13× -0.06× -0.38×
SBC % of Revenue 24.85% 13.26% 4.45% 1.17% 0.77% 11.58%
CapEx Coverage -8.71× -2.83× -3.12× 8.53× 32.12× 26.67×
Free Cash Flow Per Share $-5.37 $-10.59 $-10.78 $10.57 $30.62 $5.12

Valuation Metrics

Concept FY 2025FY 2024FY 2023FY 2022FY 2021FY 2020
P/E Trailing (Diluted) 8.93× 8.98×
P/FCF 16.99× 8.30× 20.40×
FCF Yield 5.88% 12.05% 4.90%
EV / EBITDA 6.87× 7.13×
P/S 5.98× 4.96× 5.55× 3.59× 5.54× 51.91×
P/B 1.34× 1.47× 2.74× 3.62× 7.24× 16.28×

Income Statement

Concept FY 2025FY 2024FY 2023FY 2022FY 2021FY 2020
Revenue from Contract with Customer, Excluding Assessed Tax 1.94B 3.24B 6.85B 19.26B 18.47B
Revenues 19.26B 18.47B 803.00M
Cost of Goods and Services Sold 868.00M 1.46B 4.69B 5.42B 2.62B 8.00M
Research and Development Expense 3.13B 4.54B 4.84B 3.29B 1.99B 1.37B
Operating Income (Loss) -3.07B -3.94B -4.24B 9.42B 13.30B -763.00M
Income Tax Expense (Benefit) 54.00M -46.00M 772.00M 1.21B 1.08B 3.00M
Net Income (Loss) Attributable to Parent -2.82B -3.56B -4.71B 8.36B 12.20B -747.00M
Earnings Per Share, Basic $-7.26 $-9.28 $-12.33 $21.26 $30.31 $-1.96
Weighted Average Number of Shares Outstanding, Basic 389.00M 384.00M 382.00M 394.00M 403.00M 381.00M
Earnings Per Share, Diluted $-7.26 $-9.28 $-12.33 $20.12 $28.29 $-1.96
Weighted Average Number of Shares Outstanding, Diluted 389.00M 384.00M 382.00M 416.00M 431.00M 381.00M

Balance Sheet

Concept FY 2025FY 2024FY 2023FY 2022FY 2021FY 2020
Cash and Cash Equivalents, at Carrying Value 2.60B 1.93B 2.91B 3.21B 6.85B 2.62B
Assets, Current 6.54B 8.10B 10.32B 13.43B 16.07B 6.30B
Assets 12.34B 14.14B 18.43B 25.86B 24.67B 7.34B
Liabilities, Current 1.99B 2.21B 3.02B 4.92B 9.13B 4.39B
Long-term Debt, Excluding Current Maturities 590.00M 0
Liabilities 3.69B 3.24B 4.57B 6.74B 10.52B 4.78B
Stockholders' Equity Attributable to Parent 8.65B 10.90B 13.85B 19.12B 14.14B 2.56B
Common Stock, Shares, Outstanding 394.00M 386.00M 382.00M 385.00M 403.00M 399.00M

Cash Flow Statement

Concept FY 2025FY 2024FY 2023FY 2022FY 2021FY 2020
Net Cash Provided by (Used in) Operating Activities -1.87B -3.00B -3.12B 4.98B 13.62B 2.03B
Payments to Acquire Property, Plant, and Equipment 192.00M 1.05B 707.00M 400.00M 284.00M 68.00M
Net Cash Provided by (Used in) Investing Activities 1.95B 1.95B 4.21B -5.18B -8.52B -1.67B
Payments for Repurchase of Common Stock 2.00M 0 1.15B 3.33B 857.00M 0
Net Cash Provided by (Used in) Financing Activities 593.00M 56.00M -1.38B -3.45B -873.00M 2.03B

Raw XBRL tagging for a single filing

Every us-gaap and custom concept the filer tagged for one fiscal period, grouped by statement. Start here when a number in the trend table above surprises you and you want to see the exact tag behind it. Derived and valuation rows are omitted here because they already appear in the trend table.

Most recent filing shown by default.

Compare filings side-by-side

Diff any two filings with deltas and added / removed tags.

Immaterial rows are USD line items under 1% of the period's revenue — the noise floor below which a single tag rarely moves the investment thesis. Revenue is read from the filer's top-line concept (Revenues / RevenueFromContractWithCustomerExcludingAssessedTax, with a fallback chain). Non-USD rows, rows without a numeric value, and every row on a filing with no identifiable revenue anchor stay visible. Flip the switch off to see every tag the filer reported for the period.

Loading filing details…

Methodology

All facts on this page come straight from SEC EDGAR XBRL company-facts filings (MRNA CIK 0001682852), grouped by financial statement using FASB's base us-gaap presentation taxonomy. Filers may re-parent concepts onto different statements in their own extension taxonomy, so a handful of rows can show up under a different statement than on the actual 10-K / 10-Q; custom concepts and any we couldn't map fall into Other. Hover a cell to see the fully-qualified concept name and the filer's description.

For the full methodology — statement grouping, the Other bucket, derived metrics, and fact tooltips — see the methodology reference for the statement grouping, the "Other" bucket, derived metrics, and fact tooltips.

Related tickers

CHTR

Charter Communications, Inc.

LHAI

Linkhome Holdings Inc.

SW

Smurfit Westrock plc